Form 4 for BSX Boston Scientific
Accepted 2024-05-13 00:00:00 ET · period of report 2024-05-09 · accession 0001225208-24-005970 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-05-13 | 2024-05-09 | BSX | Morano Susan E | Dir | A - Grant | $0.00 | +1,871 | 3,953 | +90% | $0 |
| DM | 2024-05-13 | 2024-05-09 | BSX | Morano Susan E | Dir | A - Grant | $0.00 | +1,871 | 3,532 | +113% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-09 | A | A | 1,450 | $0.00 | 3,532 | D | — | — | |
| 2 | Common | Common Stock | 2024-05-09 | A | A | 421 | $0.00 | 3,953 | D | — | — | |
| 3 | Derivative | Deferred Stock Units | 2024-05-09 | A | A | 421 | $0.00 | 3,953 | D | — · — to — | 421 Common Stock | (F5) Deferred stock units were granted in lieu of 25% yearly cash compensation and vest in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Directors service in accordance with the Company's Non-Employee Director Deferred Compensation Plan. Reflects a value of $31,250 (representing 25% of the amount of the non-employee director compensation program's cash retainer having a value of $125,000) divided by the closing price of the common stock on the date of grant. (F3) Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. |
| 4 | Derivative | Deferred Stock Units | 2024-05-09 | A | A | 1,450 | $0.00 | 3,532 | D | — · — to — | 1,450 Common Stock | (F4) Annual equity award in the form of deferred stock units vesting in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Director service in accordance with the Company's Non-Employee Director Deferred Compensation Plan. Reflects a value of $107,500 (representing 50% of the non-employee director compensation program's annual equity award having a value of $215,000) divided by the closing price of common stock on the date of grant. (F3) Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. |